The difference your support makes
All the progress Myeloma UK achieves is only possible thanks to you.
Thanks to your support, we’re making real advancements in the research and treatment of myeloma.
Myeloma UK is funded by people like you. People living with myeloma, family and friends supporting loved ones affected by myeloma, and those who have lost loved ones too soon.
Your generous donations, motivational fundraising activities and thoughtful gifts in wills power our work forward towards a cure.
From me and mum, a heartfelt thank you for supporting Myeloma UK
By supporting Myeloma UK, you’re ensuring the the Infoline service is there, that research is funded and that people, like mum, get access to new treatments, no matter where they live.
Michelle Clark and her mum Pauline
Together, we’re making it possible for people to live longer, better lives with myeloma
Thanks to your support, we’re making strides forward.
Successfully fought for life-extending DVRD, which can stop myeloma for over four years. DVRD is now approved on the NHS in England and Wales, benefiting 3,300 newly diagnosed patients who are not eligible for a stem cell transplant.
New National Cancer Plan for England now including a measure of early diagnosis that includes myeloma, thanks to patient voices.
Campaigned to Make Myeloma a Priority, collecting over 2,300 signatures during the Scottish and Welsh election campaigns in April, ensuring myeloma is on the political agenda.
Fought and won several treatment approvals already in 2026, and we continue work to widen access.
Access to treatment is vital
Treatment approvals highlight why we continue to fight for treatment, submit evidence on behalf of the myeloma community, provide expert testimony in committee meetings and push for access to pioneering drugs.
Until we have a cure, it is absolutely vital that all myeloma patients are given as many options to tackle their cancer as possible – no matter where they are on their treatment journey.
Dr Scott Purdon, Head of Patient Advocacy at Myeloma UK
Our progress focuses on three core areas:
Preventing myeloma
MGUS and smouldering myeloma are both precursor conditions to myeloma. Approximately 6,000 people are diagnosed with MGUS each year in the UK. By focusing on earlier diagnosis and on precursor conditions that can develop into myeloma, we want to radically reduce the proportion of people who are affected by myeloma.
Treating myeloma
By helping to deliver cutting edge treatments, policies and care standards, we want more people to move into remission for longer and help people feel a greater senses of control over their situation.
Living well with myeloma
Since we started our work, the average length of time someone with myeloma can expect to survive has quadrupled. By improving our understanding of living longer with myeloma and by offering the best support, we want to help everyone live a full life after diagnosis.
2025 Impact report
Read our 2025 impact report ‘For today and for tomorrow’ and find out more about the amazing things we achieved together in 2025.
We’re in it together
The more we learn about Myeloma UK’s work, the more we support it.
Richard and Yvette, took on the Jurassic Coast Hike for Myeloma UK
Together, we are the cure
For more than 25 years, alongside people affected by myeloma, we have delivered incredible progress. But we need to go further, faster because people living with myeloma can’t wait. Join us.
or contact our Supporter Care Team on 0131 230 0429 or email supportercare@myeloma.org.uk
Stay in touch
We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.
